BNET Industries
BSD Medical Corp. (BSDM) is in the Health Care Industry
Latest News and Analysis
BSD-2000 Cancer Treatment System by BSD Medical Installed in Prestigious Liaocheng Peoples Hospital in China
SALT LAKE CITY -- BSD Medical Corp. (NASDAQ:BSDM) today announced that another BSD-2000 hyperthermia system has been purchased, installed and is now in use in China, at the Liaocheng Peoples Hospital located in Liaocheng City, in the Western Shandong Province of the People's Republic of China. The Liaocheng Peoples Hospital...
ESMO Guideline Working Group Recommends Hyperthermia Therapy as Treatment Option for Soft Tissue Sarcoma Reports BSD Medical
SALT LAKE CITY -- BSD Medical Corp. (NASDAQ: BSDM) today reported that in the Annals of Oncology (Volume 19, Supplement 2, 2008), the European Society for Medical Oncology ESMO Clinical Treatment Guideline Working Group has published its relevant clinical treatment guidelines under "Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis,...
Italy to Receive First BSD-2000/3D Deep Regional Hyperthermia System
SALT LAKE CITY -- BSD Medical Corp. (NASDAQ:BSDM) announced today that its European distributor was awarded the contract to supply a BSD-2000/3D deep regional hyperthermia system, complete with the SigmaHyperplan hyperthermia treatment planning option and a BSD-500 local hyperthermia system, from Azienda Ospedaliera Istituti Ospitalieri Di Verona (the "Institute"). The...
Hyperthermia Therapy Featured as a 'Powerful Tool' in Cancer Treatment by ABC Television
SALT LAKE CITY -- BSD Medical Corp. (NASDAQ: BSDM) today announced the recent airing of a news segment titled "Putting the heat on cancer" on WPVI-TV (ABC Channel 6) in Philadelphia. The segment interviewed patients and clinicians at the Cancer Treatment Centers of America CTCA in Philadelphia and highlighted the...
BSD Medical Representatives to Participate in Ribbon Cutting Ceremonies for Three New BSD-2000 Cancer Treatment Systems in China
SALT LAKE CITY -- BSD Medical Corporation (NASDAQ: BSDM) reported today that opening ceremonies for the installation of three new BSD-2000 hyperthermia systems purchased in China have been announced. The new hospitals adding BSD-2000 systems to their cancer treatment programs include the Liaocheng City Hospital, located in Shandong Province, the...
Phase III Clinical Study Using BSD Medical's Systems for Treating Pancreatic Cancer to Be Announced at ASCO
SALT LAKE CITY -- BSD Medical Corp. (NASDAQ:BSDM) announced today that a team of researchers headed by Professor Rolf D. Issels will be announcing at the upcoming annual American Society of Clinical Oncology ASCO conference that a Phase III clinical study is underway involving the combined use of hyperthermia therapy...
Treating Cancer with Hyperthermia Highlighted at the Vienna Joint German and Austrian Society of Radiation Oncology Meeting
SALT LAKE CITY -- BSD Medical Corporation (NASDAQ:BSDM) announced today that several recent events have occurred in Europe that highlight the use of hyperthermia therapy in treating cancer. Following the International Congress on Hyperthermic Oncology ICHO conducted last month in Munich, Germany (see earlier press release 04-29-08), the joint annual...
BSD Medical to Present Its Cancer Therapy Systems at the 2008 World Congress of Brachytherapy
SALT LAKE CITY -- BSD Medical Corporation (NASDAQ:BSDM) announced today that the company will present its systems for cancer therapy at the 2008 World Congress of Brachytherapy the annual meeting of the American Brachytherapy Society or ABS from May 4-6, 2008, in Boston, Massachusetts. The company's objective at ABS is...
BSD Medical Announces Significant Advances in Treatment Technology at ICHO Congress in Munich
SALT LAKE CITY -- BSD Medical Corporation (NASDAQ:BSDM) today reported further highlights from more than 200 abstracts summarizing presentations at the International Congress on Hyperthermic Oncology ICHO conducted this month in Munich, Germany. This conference is the combined meeting of the European Society for Hyperthermic Oncology ESHO, the U.S. Society...
Multiple Studies Demonstrate the Use of Hyperthermia Therapy in Treating Pancreatic Cancer
SALT LAKE CITY -- BSD Medical Corporation (NASDAQ:BSDM) today began to report highlights from 204 abstracts summarizing presentations at the International Congress on Hyperthermic Oncology ICHO conducted this month in Munich, Germany. This conference is the combined meeting of the European Society for Hyperthermic Oncology ESHO, the U.S. Society of...
BSD Medical Submits 510 Premarket Notification for MicroThermX®-100 Microwave Ablation System
SALT LAKE CITY -- BSD Medical Corporation (AMEX:BSM) today announced that the company has provided its 510k Premarket Notification submission to the Food and Drug Administration FDA for the MicroThermX-100 Microwave Ablation System. The MicroThermX-100 Microwave Ablation System represents a major step into another market for BSD's products. Clearance from...
BSD Medical plans to switch its listing to Nasdaq market
BSD Medical Corp. said this week that its board of directors has approved switching the listing of the Salt Lake-based company's common stock from the American Stock Exchange to the Nasdaq Stock Market. Trading under the symbol BSDM will begin April 22. The company...
BSD Medical Corporation to Be Listed on the NASDAQ Stock Exchange
SALT LAKE CITY -- BSD Medical Corporation (AMEX:BSM) announced today that its board of directors has approved the decision to switch the listing of its common stock from the American Stock Exchange to the NASDAQ Stock Market LLC([R]). Effective April 22, 2008, the company will trade under the symbol NASDAQ:BSDM,...
BSD Medical Cites Highlights from Its Second Quarter 2008 Report
Second Quarter Sales Up by 123% SALT LAKE CITY -- BSD Medical Corp. (AMEX:BSM) announced that the company has filed its second quarter report with the Securities and Exchange Commission, and released highlights of results for the second quarter ended February 29, 2008 and first half of its...
ASTRO's Official Journal Publishes 12-Year Survival Data Following Landmark Study of Cancer Treatment with Hyperthermia Therapy
SALT LAKE CITY -- BSD Medical Corp. (AMX:BSM) today announced that the International Journal of Radiation Oncology, Biology and Physics has published a 7-page report containing the 12-year clinical follow-up data for a landmark study comparing the clinical results for advanced cervical cancer patients treated with radiation and hyperthermia therapy...
Review of Data from Eight U.S. Cancer Institutions Supports Use of Hyperthermia with Radiation for Treating Recurrent Breast Cancer
Complete Tumor Response Was 67% for Patients Receiving Radiation Plus Hyperthermia vs. 39% for Patients Receiving Radiation Alone SALT LAKE CITY -- BSD Medical Corp. (AMEX:BSM) today reported that the official journal of the American Society for Therapeutic Radiology and Oncology ASTRO, commonly known as "The Red Journal,"...
2008 ACRO Practice Management Guide Introduces Two Chapters on Hyperthermia Therapy
SALT LAKE CITY -- BSD Medical Corporation (AMEX:BSM) today announced that the American College of Radiation Oncology ACRO has dedicated two of the twenty chapters in its 2008 Practice Management Guide to hyperthermia therapy in treating cancer. The new guide was released at the 18th annual ACRO conference held in...
Keynote Lecture on Hyperthermia Therapy Receives Standing Ovation at Biannual Meeting of the German Cancer Society
SALT LAKE CITY -- BSD Medical Corporation (AMEX:BSM) today announced that Rolf Issels, MD, PhD gave the keynote lecture at the biannual meeting of the German Cancer Society held February 20-24, 2008 using as his subject the clinical application of hyperthermia therapy in treating cancer. The lecture, entitled "Heat Is...
BSD Medical Participates on Invitation at International Conference on Hyperthermic Oncology and Medicine in India
SALT LAKE CITY -- BSD Medical Corporation (AMEX:BSM) today announced that Richard A. White, Vice President of International Sales, along with some of the leading researchers in hyperthermia therapy, spoke and participated in a panel discussion as invited guests at the International Conference on Hyperthermic Oncology and Medicine held at...
CHAT LIVE in the only dedicated CHAT ROOM for BSD Medical (AMEX: BSM) shareholders!
M2 PRESSWIRE-13 February 2008-Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for BSD Medical (AMEX: BSM) shareholders!C1994-2008 M2 COMMUNICATIONS LTD RDATE:13022008 AUSTIN, TX -- STOCKWIRE.com, one of the largest investment websites on the internet, is proud to announce...
- Next »
- page 1 of 8
- « Previous
- Incorporated: 1978
- Employees: 41
BSD Medical is engaged in the development, manufacturing, marketing and servicing of medical systems that deliver radio frequency or microwave energy into diseased sites of the body, heating them to specified temperatures as required by a variety of medical therapies. Co.'s BSD-2000 and BSD-500 cancer treatment systems are used to treat cancer with heat, and are designed to boost the effectiveness of radiation and chemotherapy through a number of biological mechanisms. Co.'s MicroThermX 100 system is used to treat cancers with heat alone. Co.'s systems are sold worldwide.
Key Competitors
BSD Medical Corp. Company Info
Board of Directors
Mr. Paul F. Turner
Chairman
Mr. Hyrum A. Mead
Dr. Gerhard W. Sennewald Ph.D.
Dr. Michael Nobel Ph.D.
Dr. Douglas P. Boyd Ph.D.
Mr. Steven G. Stewart CPA
Mr. Timothy C. McQuay
Contact Information
2188 West 2200 South
Salt Lake City, UT
801 972-5555
NAICS Code
Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510Brought to you by IBMSponsored Resources
